【医疗健康周报】第12周：创新疫苗和佐剂开发商“华诺泰生物”获得6亿元人民币B轮融资；生物制药公司“CymaBay”以约43亿美元被吉利德并购

钛媒体APP03-27

（本文为钛媒体Pro（专业版）用户专享）行业报告目录报告全文5840字，插图6张1、行业重点导读2、一级市场动态2.1、国内一周融资动态（图：融资项目详情/领域/阶段）2.2、国内钛媒体Pro·项目推荐2.3、国外一周融资动态（图：融资项目详情/领域/阶段）2.4、国外钛媒体Pro·项目推荐3、行业观察4、行业政策重·点·导·读医疗健康领域全球投融资项目共收录45起，国内融资22起，国外融资23起...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2422529449?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-27 16:37","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2422529449","market":"us","top_or_hot":-1,"title":"【医疗健康周报】第12周：创新疫苗和佐剂开发商“华诺泰生物”获得6亿元人民币B轮融资；生物制药公司“CymaBay”以约43亿美元被吉利德并购","media":"钛媒体APP","content":"<div>\n<p>（本文为钛媒体Pro（专业版）用户专享）行业报告目录报告全文5840字，插图6张1、行业重点导读2、一级市场动态2.1、国内一周融资动态（图：融资项目详情/领域/阶段）2.2、国内钛媒体Pro·项目推荐2.3、国外一周融资动态（图：融资项目详情/领域/阶段）2.4、国外钛媒体Pro·项目推荐3、行业观察4、行业政策重·点·导·读医疗健康领域全球投融资项目共收录45起，国内融资22起，国外融资23起...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271642038b68fa12&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【医疗健康周报】第12周：创新疫苗和佐剂开发商“华诺泰生物”获得6亿元人民币B轮融资；生物制药公司“CymaBay”以约43亿美元被吉利德并购</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【医疗健康周报】第12周：创新疫苗和佐剂开发商“华诺泰生物”获得6亿元人民币B轮融资；生物制药公司“CymaBay”以约43亿美元被吉利德并购\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-27 16:37 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271642038b68fa12&s=b><strong>钛媒体APP</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>（本文为钛媒体Pro（专业版）用户专享）行业报告目录报告全文5840字，插图6张1、行业重点导读2、一级市场动态2.1、国内一周融资动态（图：融资项目详情/领域/阶段）2.2、国内钛媒体Pro·项目推荐2.3、国外一周融资动态（图：融资项目详情/领域/阶段）2.4、国外钛媒体Pro·项目推荐3、行业观察4、行业政策重·点·导·读医疗健康领域全球投融资项目共收录45起，国内融资22起，国外融资23起...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271642038b68fa12&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0320765992.SGD","symbol_name":"FTIF - Franklin Biotechnology Discovery A Acc SGD","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271642038b68fa12&s=b","article_id":"2422529449","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271642038b68fa12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2422529449","pubTimestamp":1711528648,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"国内投融资方面，医药领域，创新疫苗和佐剂开发商“华诺泰生物”获得6亿元人民币B轮融资，核医学CRDMO“米度生物”融资近4亿元人民币。国外投融资方面，医药领域，生物制药公司“CymaBay”以约43亿美元被吉利德并购；生物技术领域，生物技术公司“Capstan Therapeutics”在B系列融资中筹集了1.75亿美元。医药“华诺泰生物”获得6亿人民币B轮融资日前，“华诺泰生物”正式宣布完成总额6亿元B轮融资。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BK4585":"ETF&股票定投概念","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4139":"生物科技","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A","BK4566":"资本集团","BK4578":"CAR-T","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","BK4588":"碎股","BK4550":"红杉资本持仓","LU2087621335.USD":"ALLSPRING GLOBAL FACTOR ENHANCED EQUITY \"A\" (USD) ACC","BK4568":"美国抗疫概念","GILD":"吉利德科学","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","BK4583":"猴痘概念","BK4532":"文艺复兴科技持仓","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC"},"translate_title":"Week 12 of Medical Health Weekly: The innovative vaccine and adjuvant developer \"Huanuotai Bio\" received 600 million yuan in round B financing; Biopharmaceutical company \"CymaBay\" was acquired by Gilead for about $4.3 billion","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GILD":0.9},"content_text":"（本文为钛媒体Pro（专业版）用户专享）行业报告目录报告全文5840字，插图6张1、行业重点导读2、一级市场动态2.1、国内一周融资动态（图：融资项目详情/领域/阶段）2.2、国内钛媒体Pro·项目推荐2.3、国外一周融资动态（图：融资项目详情/领域/阶段）2.4、国外钛媒体Pro·项目推荐3、行业观察4、行业政策重·点·导·读医疗健康领域全球投融资项目共收录45起，国内融资22起，国外融资23起。从融资领域来看，国内医疗器械及硬件领域有投融资11起，位居第一，医药领域10起，位居第二；国外生物技术领域有投融资8起，位居第一，医疗信息化、医疗器械及硬件领域各5起，并列位居第二。国内投融资方面，医药领域，创新疫苗和佐剂开发商“华诺泰生物”获得6亿元人民币B轮融资，核医学CRDMO“米度生物”融资近4亿元人民币。国外投融资方面，医药领域，生物制药公司“CymaBay”以约43亿美元被吉利德并购；生物技术领域，生物技术公司“Capstan Therapeutics”在B系列融资中筹集了1.75亿美元。自2024年3月18日起至2024年3月24日，钛媒体TMTBASE全球一级市场数据库总计收录国内、国外医疗健康赛道投融资事件共45起，其中国内融资22起，国外融资23起。国内一周融资动态.过去一周钛媒体TMTBASE全球一级市场数据库总计收录发生在国内医疗健康领域的投融资事件22起，环比增长22.22%。. 从融资数量上看，医疗器械及硬件领域有投融资11起，医药领域10起，医疗信息化领域1起。. 从融资轮次上看，天使轮3起，天使+轮、Pre-A轮、Pre-A+轮各1起，A轮、A+轮各2起，Pre-B轮1起，B轮3起，D+轮1起，股权投资7起。. 过去一周披露的亿级（人民币）以上融资额项目为2起，全部来自医药领域。医药“华诺泰生物”获得6亿人民币B轮融资日前，“华诺泰生物”正式宣布完成总额6亿元B轮融资。本轮融资由北京市医药健康产业投资基金与华银金投旗下明泰基金联合领投，并由水木春锦资本、国管旗下顺禧基金、本草资本以及晋成基金等共同完成投资。百榕资本担任本轮融资的独家财务顾问。华诺泰生物是一家创新疫苗和佐剂开发商，致力于疫苗领域的创新产品开发，打造核心技术平台，推动国内上市疫苗产品的更新换代。华诺泰拥有包括佐剂技术平台、载体技术平台、抗原筛选技术平台等核心技术，其中佐剂技术平台将对国内疫苗领域起到颠覆性作用。核医学CRDMO“米度生物”融资近4亿元日前，烟台东诚药业集团股份有限公司公告，同意下属子公司米度（烟台）生物技术有限公司（以下简称“米度”或“公司”）增资扩股，由国投招商领投，国投聚力、山东地方产业基金等跟投，合计融资人民币近4亿元。米度在烟台、南京、无锡、广州等地均有布局，主要业务为以核医学技术为基础，为国内外药企客户提供CRDMO服务。米度资质齐全，设施完备，现拥有AAALAC认证的放射性实验室，可满足国内外动物福利标准；拥有26种核素资质，可满足各项实验要求；是一家拥有临床及动物PET/CT的CRO企业，可实现大、小动物连续动态和静态扫描。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2422529449"}